Noel Pugh on bypassing seed rounds, revenue-first fundraising, and venture debt covenants
Summary
Noel Pugh explains how she navigated a 2023-2024 funding crunch by securing a $1.8M pre-seed extension to avoid a traditional seed round, citing investor hesitation and a lead investor's conflict. She emphasizes a revenue-first approach, leading pitch decks with gross profit margins and revenue stats rather than technology, and designing for a future cash-pay model to reduce reliance on CPT code reimbursements. Pugh details securing venture debt from Live Oak with strict $5M ARR covenants, requiring lean operations and auditable books. Host Nassim highlights systemic barriers for female founders, including venture debt firms rejecting cap tables unfamiliar to credit teams, and notes the importance of founder financial literacy and resilience.
Key takeaways
- 1 Designing technology for a 'future state' where current reimbursement codes (CPT) may not exist is critical for long-term viability in healthcare.
Unidentified speaker (speaker_0) · 37:29
Episode sections
- 0:00 – 0:27
Lead Investor Conflict and Round Restructuring
Noel Pugh recounts a lead investor committing $4M then questioning her operator skills, prompting her to reject the terms. She pivoted to a pre-seed extension strategy to bypass the seed round and accelerate toward Series A.
- 0:27 – 4:26
Podcast Intro and Founder Background
Host Nassim introduces the podcast's focus on female founder fundraising challenges. She details her history with Pugh, leading a pre-seed extension and witnessing the rapid transition to an $8M Series A.
- 4:26 – 25:43
Funding Crunch and Pre-seed Extension Strategy
Pugh describes the 2023-2024 funding crunch where growth narratives failed. She secured a $1.8M pre-seed extension to bridge to Series A, avoiding a traditional seed round due to investor hesitation.
- 25:43 – 30:47
Venture Debt and Cap Table Dynamics
Nassim discusses a systemic barrier where venture debt firms reject female-founded companies because credit teams do not recognize their cap tables. Pugh confirms this lack of familiarity with femtech/maternal health sectors.
- 30:47 – 32:54
Pitch Deck Iteration and Storytelling
Speaker_0 describes reworking a broken pitch deck with a friend from Advisory Board, leading with revenue stats and gross profit margins to create an 'expensive' look. Nassim notes the importance of balancing founder ownership of the story with constructive feedback.
- 32:54 – 34:09
Commercialization Criteria and Revenue-First Approach
Speaker_0 outlines two pillars for strategic decisions: bearing revenue and providing better outcomes for mothers. She emphasizes building technology to support a proven revenue story rather than leading with tech, citing CPT codes as the basis for their model.
- 34:09 – 36:40
Investor Education and Angel vs. VC Dynamics
Speaker_0 advises against spending excessive time educating investors on complex verticals, preferring to find those who inherently understand the model. She contrasts this with Sandhill Angels who 'got it' and angels who invested based on belief in the founder.
- 36:40 – 39:51
Reimbursement Risk and Future-State Modeling
Speaker_0 discusses designing for a future state beyond CPT-based reimbursement, aiming for a $99/month cash-pay model. Nassim agrees, citing a cash-pay portfolio company that scaled from $30M to $250M valuation, arguing against the necessity of reimbursement hooks for scale.
- 39:51 – 42:58
Venture Debt Covenants and Operational Rigor
Speaker_0 details securing venture debt with Live Oak, requiring $5M ARR covenants and high transparency. She highlights the need for lean operations, auditable books, and mission-aligned lenders like Alex at Live Oak to negotiate interest-only periods.
- 42:58 – 45:18
Founder Financial Literacy and Model Ownership
Speaker_0 states she is the financial model, correcting assumptions made by her COO and switching accounting firms after the Marble Bridge process. She emphasizes that founders must live and breathe their P&L to survive.
- 45:18 – 48:08
Early Capital from Customers and Angels
Speaker_0 recounts raising $1.2M from an angel (Magella SBV) after a personal connection and receiving checks from customers and family. Nassim highlights the importance of clarity of vision, continuous fundraising, and tangible product impact (e.g., reduced office emergencies).
- 48:08 – 51:01
Advice for Female Founders and Resilience
Speaker_0 shares lessons on angel vs. VC narratives and her top three 'must-nos' for female founders: rest on female support, show/earn numbers via bootstrapping, and maintain resilience through daily rituals and self-investment.
Claims worth verifying
A lead investor committed to a $4 million round at a luncheon but later told Noel Pugh she was a 'sales girl' and not an operator, leading Pugh to reject the terms.
Unidentified speaker (speaker_0) ·0:00
How to verify: Check Lōvu Health's SEC Form D filings for the $4M commitment and subsequent funding rounds; review news archives for the specific investor name if disclosed in other sources. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceNoel Pugh closed an $8 million Series A less than 12 months after a $1.8 million pre-seed extension, skipping the seed round.
Unidentified speaker (UNKNOWN) ·3:47
How to verify: Verify via SEC Form D filings for Lōvu Health's Series A filing date and amount, and the pre-seed extension filing date. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceLōvu Health partnered with Providence, a major healthcare delivery system in the Pacific Northwest.
Unidentified speaker (speaker_0) ·7:54
How to verify: Check Lōvu Health's website, press releases, or partnership announcements for mentions of Providence Health. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Marble Bridge was brought in for factoring and borrowing against receivables.
Unidentified speaker (speaker_0) ·10:46
How to verify: Search Marble Bridge's portfolio page or Lōvu Health's press releases for the factoring arrangement. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Venture debt decisions are often based on whether the credit team knows the company's cap table, not just revenue.
Unidentified speaker (UNKNOWN) ·27:28
How to verify: Review Nassim's LinkedIn post referenced in the transcript or industry reports on venture debt underwriting criteria. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceLōvu Health achieved approximately $1.2 million ARR at the time of the Series A close, which later hit $5 million.
Unidentified speaker (UNKNOWN) ·18:29
How to verify: Check Lōvu Health's press releases or investor updates for ARR milestones; verify the $5M figure in later filings or announcements. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceLōvu Health reduced total cost of care by $1.2 million across 888 patients.
Unidentified speaker (UNKNOWN) ·18:29
How to verify: Review Lōvu Health's white papers, case studies, or investor decks for specific cost-of-care metrics. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
The platform detected emerging pre-eclampsia in 8% of patients and suicidal ideation in 9% of patients.
Unidentified speaker (speaker_0) ·18:49
How to verify: Check clinical studies, white papers, or press releases from Lōvu Health detailing clinical outcomes. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Fidelity Private Shares is a sponsor providing cap table management.
Unidentified speaker (UNKNOWN) ·24:23
How to verify: Check the podcast's sponsor page or Fidelity Private Shares' website for partnership announcements. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Venturous Counsel is a sponsor law firm offering legal services.
Nassim ·24:43
How to verify: Check the podcast's sponsor page or Venturous Counsel's website for partnership announcements. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Advisory Board is still called Advisory Board and is considered a top sales engine in healthcare.
Unidentified speaker (speaker_0) ·30:47
How to verify: Company website or press releases; industry reports on healthcare sales organizations. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
The TAM for Lōvu Health is a one trillion dollar annual opportunity if extrapolated to all individuals in the US.
Unidentified speaker (speaker_0) ·31:47
How to verify: Lōvu Health pitch deck or investor presentation materials; market research reports on women's health spend. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Lōvu Health's revenue model is based on CMS-based CPT codes.
Unidentified speaker (speaker_0) ·36:50
How to verify: Lōvu Health financial filings or investor presentations; CMS.gov CPT code databases. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceA cash-pay portfolio company of Nassim's went from a $30 million valuation to $250 million.
Unidentified speaker (UNKNOWN) ·38:49
How to verify: Nassim's fund disclosures or press releases about the specific portfolio company; Crunchbase or PitchBook data. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Lōvu Health had to hit $5 million ARR to satisfy venture debt covenants.
Unidentified speaker (speaker_0) ·40:20
How to verify: Venture debt term sheets or SEC filings if public; press releases announcing the debt round. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceMagella SBV invested $1.2 million in Lōvu Health.
Unidentified speaker (speaker_0) ·45:37
How to verify: Cap table disclosures in investor updates; SEC Form D filings for the round. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceAlan Nunn runs logistics for All of Lovu and was a large angel investor.
Unidentified speaker (UNKNOWN) ·48:49
How to verify: LinkedIn profiles; company press releases or investor announcements. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Lōvu Health switched accounting firms after the Marble Bridge process.
Unidentified speaker (speaker_0) ·45:07
How to verify: Company press releases or internal announcements; Marble Bridge case studies. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Lōvu Health is designing for a future state where the model could be 90% agentic.
Unidentified speaker (speaker_0) ·39:25
How to verify: Lōvu Health product roadmap or investor presentations on AI/automation strategy. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
An angel investor invested $1.2 million after a meeting in San Antonio, Texas.
Unidentified speaker (speaker_0) ·45:37
How to verify: Investor interviews or company history blogs; SEC filings. For recent events, verify 2026-08-18 through 2026-11-18. Use another period only when the speaker explicitly names it.
Primary sourceDo your own research
- Verify Noel Pugh's company name and current valuation via Crunchbase or PitchBook.
- Check Live Oak Banking's venture debt terms and covenants for similar-stage healthcare startups.
- Review CPT code reimbursement trends for maternal health services via CMS.gov.
- Assess the $99/month cash-pay model's scalability against insurance reimbursement risks.
- Confirm the $1.8M pre-seed extension terms and investor list via SEC Form D filings.
- Research venture debt rejection rates for female-founded companies in femtech.
- Evaluate the founder's financial literacy by reviewing the company's P&L and audit history.
- Look for counter-arguments to the 'revenue-first' approach in early-stage healthcare VC literature.
Full transcriptexpand
0:00Unidentified speaker (speaker_0): My lead comes to me who had committed at a luncheon with my entire team to a four million dollar round, says, Noelle, you're a sales girl. You're not an operator. Get out there and sell more. You need to bring more clients on so you can be investable. She never said, I'm not going to invest in you. I walked out of that meeting and I said, We're not a match. I'm a founder. I'm not a sales girl.
0:27Nassim: Thank you so much. This has been an incredible adventure to put this event on because I think Jess and I have been talking about it. She's my producer back there. Uh, have been talking about doing a live event for at least a year. And and finally, then when you called and said, Hey, we're doing this, like, oh my God, it's here. So I have to thank the whole team who did all the coordination and all the details to get us to where we're at right now, because this is the first. of hopefully many of live conversations. My name is Nassim. I'm a VC, I've been in the space for about seven years. I only invest in female founded teams. I've been trying to move the needle on the 2% for some time. And a lot of what's happened in the course of that is I meet a lot of founders and I hear a lot of stories. A lot. And it's it's all the good stuff, yes, but mostly the really hard stuff. It's the weird meetings, it's the weird glances, it's the predatory terms, it's the explicitly bad behavior. The kind of stuff is it's beyond. And I know there's like stories in the room that I've heard and some that I probably haven't heard yet. And so I had a posted on my desk for like two years. So I just need to make a podcast out of these things because I'm connecting founder A to Founder B pretty constantly, but we need to scale the inside. insight somehow. And so finally last year, had some time to sit and actually strategize doing this. And from that came The Capital Flex,
1:47which is a podcast entirely about the fundraising stories of female founders and the really hard stuff. And not just the stories, but really what was the learning? What's the insight, and how can it help other founders navigate better before you walk into the room? So we're two seasons in. Uh it's out on all the platforms where you can find your podcasts. And uh I'm currently recording season three. This episode will go into season three. And I'm so glad you're here because the more we elevate and talk about these things, the more we actually share knowledge, build community, and the more we shift the system because the more we know what's going on, the more it doesn't get normalized, and the more the cash will move. So I appreciate all of you joining me. I have to intro introduce no Noelle. Uh Noelle Pugh is the founder and CEO of Lovu Health. We've known each other for about four years now, which in founder life is a really long time. And we met when she was first working through the end of a pre-seed, thinking about a seed raise. And we met at a dinner here in San Francisco and happened to start talking, and she mentioned what she was building. And I said, I'm looking for solutions that are at the intersection of women's health and AI. And without missing a beat, she
2:55Unidentified speaker (UNKNOWN): said,
2:55Nassim: Oh, that's exactly what we're doing. I was like, Oh, really? Tell me more. Told me more. We committed to talking again. We met again at uh JPM the following January. And at that point, she was ready to move on a race and said, We're looking for a lead. Can we talk? And I said, Well, yes, let's talk. And six, seven months later, my previous fund, I was leading her pre-seed extension, uh, which was fantastic because and we'll talk about this, but it was intended to achieve certain goals. And then from that around, she has a wonderful co-founder named Santosh, who I have to say his name out loud, otherwise, somewhere in the world he'll growl at me. And was it then 12 months later? The series A.
3:38Unidentified speaker (speaker_0): Yeah.
3:39Nassim: So from a one,
3:40Unidentified speaker (speaker_0): actually not even.
3:41Unidentified speaker (UNKNOWN): Not even. Not even less than that.
3:43Unidentified speaker (speaker_0): It closed then, but yeah, it
3:44Unidentified speaker (UNKNOWN): was a half.
3:45Nassim: Yeah,
3:46Unidentified speaker (speaker_0): we had to lead for
3:47Unidentified speaker (UNKNOWN): the yeah.
3:47Nassim: So from a roughly 1.5, 1.8 million pre-seed round pre-seed extension that I led, they rolled from that into an 8 million series A less than 12 months later. Hopped right over the seed and have been racing like hell ever since. And it's for me, it's one of the best checks I ever wrote. And it's been phenomenal to see the company grow. So congratulations.
4:11Unidentified speaker (speaker_2): Thank you.
4:11Nassim: Yeah. We're going to jump in to the stuff. And I would love for you, if you want to introduce yourself a little bit more, tell us a little bit about the company, and then take us through where you were at early in the those that when I first met you during those pre-seed days.
4:26Unidentified speaker (speaker_0): Before I say much more, with just absolute honor and humility, thank you for coming today and for witnessing the story of Lovu Health. You are going to hear the passion, the emphasis behind the founding journey, all the way to how we got funded. And as I share that story, one of the things that has served our firm well is. the ability to be authentic and to connect. So I'm sharing this with you because I'm connecting with you and I'm present with you today. Geez, what a time. You know, there's the fake it till you make it. There's the you're in absolute desperation, but you can't let it show. We were in the 2023 meets 2024 funding crunch. Folks might remember when banks like Silicon Valley crashed.
5:19Unidentified speaker (UNKNOWN): Um,
5:20Unidentified speaker (speaker_0): and it really caused a pause on what could be investable. I am a recovering healthcare operator. I hail from organizations like HCA, Born's Jewish. I know how to manage to PL, I know how to manage to operating margins, I know how to hire, I know how to fire. As a founder in the Silicon Valley, you're told you don't even know need to show revenue, you're pre-revenue, you just need to show growth. Well, that story was still being told during this funding crunch. No, it was the wrong story. What you needed to put up were hard, cold numbers of a highly investable, successful business. And you had to do it on, frankly, what was angel invested meets bootstrapped. And that meant many of your nights were spent in desperation, sleeping maybe five to six hours at best, high cortisol levels, because you didn't know how you were going to make payroll. In the meantime, you're jumping every plane you can, going to every dinner you can, trying to present. as a put together, brandable, investable founder that actually has something worth giving money to. So those halls and the rooms in which I met Nassim, you can't
6:39possibly know how scared we were. But we knew we were sitting on something deeply and highly investable. I think part of what Nassim had. not yet heard was the story of pre-seed extension. How did we land there? And I think for any founder that is coming after what happened in 2022 meets 2023, the strategy behind capital must be super creative and super thoughtful. And you have to read the signal for the noise. So I put together a pre-seed round. that got invested in. We had a strong valuation. Um, it was bold, 15 million. And I was beginning to show the ARR to justify it. But when it came to putting together a seed round, I'd identified a lead.
7:28Nassim: Yeah, you had a lead, right?
7:29Unidentified speaker (UNKNOWN): I had a lead.
7:30Nassim: And then they fell through?
7:31Unidentified speaker (speaker_0): Whoa, did they fall through?
7:33Nassim: Tell us, tell us that
7:34Unidentified speaker (UNKNOWN): story.
7:34Unidentified speaker (speaker_0): When you're operating a business, it's going gonna to ebb and flow. We didn't have a client term. We had uh clients and that in this point, we had partnered with the likes of uh major healthcare delivery systems in the Pacific Northwest, like Providence. We had partnered with uh a handful of clinicians in the Bay Area, and the model was really beginning to prove itself. But we had a major clinical practice that blew up, basically went out of business. Um, we had another clinical practice in Southern California that. shuttered its doors. They stopped seeing OB patients. And so what shows up is: well, it looks like you know, anemic growth. And my lead comes to me who had committed at a luncheon with my entire team to a $4 million round in New York, says, Noelle, you're a sales girl. You're not an operator. Get out there and sell more. You need to bring more clients on so you can. be investable. She never pulled back the terms. She never said, I'm not going to invest in you. I walked out of that meeting and I said, We're not a match.
8:39I'm a founder. I'm not a sales girl.
8:42Nassim: You might be really good at sales, but that's not
8:44Unidentified speaker (UNKNOWN): Oh,
8:44Unidentified speaker (speaker_0): for sure. And like always be closing, always be exiting. And what was shocking to me is that it was another feeling. female.
8:51Nassim: Well, this is it's not an uncommon experience that the prevention mindedness, the uh sharp elbows of what happens on the male investor side of the ecosystem, current company excluded, will trickle over into how some female BCs operate. Absolutely. For the sake of appearance, for the sake of being accepted, et cetera, et cetera. Uh So I'm not I'm not surprised.
9:14Unidentified speaker (UNKNOWN): Exactly.
9:15Unidentified speaker (speaker_0): So I was actually coached by this individual to stop saying I'm honored to be in a room, to code shift, to speak VC, to literally change my identity as I talked about our firm and who I am to lose some of my passion, to have more swagger. And so I knew I called one of my early institutional checks. Um, and she goes, You need snaps. Yes. Yeah,
9:39Unidentified speaker (UNKNOWN): she's awesome.
9:39Unidentified speaker (speaker_0): Snaps. Death drop. Um she says we got to find a new lead. And I said, we've got to reconstruct the round. We need to rethink about how we're positioning right now. And I said, I have some really good folks who are monitoring us. I think we're gonna go to A faster than people realize. And I'm two contracts away from reading the A, meeting the ARR to get to A. I don't need a seed, I need a pre seed pre-seed extension. And I need to put together a sweetheart deal so I can get my hands on a cool, cold one five, maybe even a little more, just to get me to the A. Nobody was thinking like this. Yeah. Nobody was. And that was the level of creativity necessary. That was the sales
10:20Unidentified speaker (UNKNOWN): girl coming in. Well, and That
10:21Nassim: was we sat at lunch in New York after
10:23Unidentified speaker (UNKNOWN): the
10:24Nassim: tech week event and and mapped out the round. Yeah. Yeah. At the at the Smith. If you
10:29Unidentified speaker (UNKNOWN): know
10:29Nassim: the Smith in New York, that's where we sat and and figured this out.
10:32Unidentified speaker (speaker_0): Had several glasses of champagne.
10:34Unidentified speaker (UNKNOWN): Highly recommend.
10:36Nassim: Wonderful.
10:36Unidentified speaker (speaker_0): Um and it was the conviction of Nassim. Um, and then Siphonic. Symphonic came in as a co-lead
10:45Unidentified speaker (UNKNOWN): around the round.
10:46Unidentified speaker (speaker_0): Yep. And we pulled together one 1.8. point eight. Um, about that time we did um uh bring in Marble Bridge for purposes of uh factoring and borrowing against what was our receivables. And um, long story short, every relationship that I got on a plane to go chase to say, I'm just gonna have a five minute conversation with you showed up for that series A conversation. So there was an initial eight. at portfolio came in right at the end. And then we pulled in about 4 million of venture debt as well. And the the that tenacity around really managing to your margins, making sure your business is highly investable, daring to dream that a tech-enabled services This company could move from, let's say, 60% gross profit margin to 75%. to 80%, to showing how you can map that out. That's what makes the banks find you sexy. And pulling in that venture debt has been the it's just a really beautiful way of constructing around so that you're taking on non-dilutive, dilutive together and just creating a highly investable situation. And then I can actually reveal this as a result of that, a channel partner. has come in and invested. And that's a major
12:05genetic testing company, not invested, placed in an operating capital loan of $1.5 million. So we now have institutions, organizations, big commercial entities also putting working capital in the firm because we help to meet their aims.
12:21Nassim: It's fucking brilliant. Oh,
12:23Unidentified speaker (speaker_0): thank you.
12:24Nassim: Congratulations.
12:24Unidentified speaker (UNKNOWN): Thank
12:24Unidentified speaker (speaker_0): you. Lots of advisories. advisory.
12:25Unidentified speaker (UNKNOWN): That's Amazing.
12:26Nassim: Coffee
12:26Unidentified speaker (UNKNOWN): at
12:26Unidentified speaker (speaker_0): Farley's with
12:27Unidentified speaker (UNKNOWN): fast.
12:27Nassim: So let's dig in a little bit on what is the outcome story that you just described, which is amazing. Uh but there were, as there are, there's bumps along the way. There was uh a couple of things that shifted. So there was at least one investor who wouldn't invest because she didn't like you. Yeah. How there's maybe two. We'll only talk about the one. Yeah. Yeah. Uh tell us how you navigated that and what did you learn?
12:57Unidentified speaker (UNKNOWN): Can
12:57Unidentified speaker (speaker_0): I real tell the real story? You we
12:59Nassim: can't no names.
13:00Unidentified speaker (UNKNOWN): No names. Be a little careful. Oh
13:02Unidentified speaker (speaker_0): my God, who wants the tea? I'm not going to be a personality match with everybody, but what I do know is our platform saves lives and it makes money and it stabilizes in an environment called the healthcare delivery system. It's almost a moral imperative when she once you see the model to not look away. So I was baffled that somebody could say that there was a personality conflict that would enable them not to want to invest in me. I I'm not going to go through the series and lines of questions that were asked of me, all to say questioning me about who my best friends are and what I do on vacation has nothing to do with whether or not my business is investable, but it was asked of me. Yeah. In order to get the check in the round, how did I get it done?
13:43Unidentified speaker (UNKNOWN): It
13:43Nassim: was like playing chess. Play chess.
13:46Unidentified speaker (UNKNOWN): Yeah, I called
13:46Unidentified speaker (speaker_0): Nis, I called Nassima, who said we got something difficult we need to work through. This is what I'm thinking. What if I called somebody on Sand Hill Road from a really big fund who's got us on monitor for A? And what if I had them make a personal phone call today on a Sunday?
14:02Unidentified speaker (UNKNOWN): I'm
14:02Unidentified speaker (speaker_0): not going to name the firms, but a big phone call was made on a Sunday by someone on Sand Hill Road from a top tier, we're talking you know the name fund, to call this other individual and say, you need to invest. It's sexy. You're going gonna to miss out. So we literally needed to manufacture FOMO on a Sunday.
14:26Nassim: And signal that could be believed, right? Exactly.
14:29Unidentified speaker (UNKNOWN): Because
14:29Nassim: then some of the background, the investment memo was done because I had seen it. It was beautiful. It was written. There was lots of diligence had to be done. Providers had been spoken to, validating that it was in use and in place. And yet there was a hesitation because I just don't like her. And the conversations that I had with this person. to say, well, that I appreciate that. But it actually doesn't matter because we're talking about this is about money. And yes, we have to get along, and so we'll be friends for 10, 12 years, whatever it is. But you don't say no to a good deal because someone didn't say hi to you properly on the Zoom call. And so you made this happen.
15:11Unidentified speaker (UNKNOWN): Oh,
15:11Unidentified speaker (speaker_0): and by the way, when you're busy saving lives, sometimes you miss moments. Perhaps I did. Whoops. Sorry, guys. I mean
15:21Nassim: that
15:21Unidentified speaker (speaker_2): was so that,
15:22Nassim: and if I remember correctly, the phone call happened sometime on Sunday afternoon, and then the deal was over the line by that evening.
15:28Unidentified speaker (speaker_0): Yeah, that's exactly right. So, I mean, if if you want to talk about the real issue, the real issue wasn't my personality. The real issue was how'd how I manage managed an ego? And sometimes it takes a lot of creative process to manage the ego.
15:42Nassim: Yeah. Oh, absolutely. Yeah. The other thing I know you did was shift the storytelling.
15:48Unidentified speaker (UNKNOWN): Oh,
15:48Unidentified speaker (speaker_2): for sure.
15:49Nassim: Uh, from where you started to then what actually ended up resonating. Take
15:53Unidentified speaker (UNKNOWN): us through that
15:54Unidentified speaker (speaker_0): for sure. Well, we were so used to positioning to our market. So I truly believe, of course, I'm the founder, so I'm biased. We have unprecedented product market fit. Our platform effectively creates a win-win-win across the delivery system. So if you're a clinician who is using our tech enable platform, you will realize revenue off of that platform. You will decrease your workflow. And by the way, maternal health, we're in OB care. We're an augmented care model, effectively redesigning how OBs think about care and taking approximately 30%. of their workflow off of their backs and putting it into a tech-enabled CPT code, otherwise known as it pays for itself via insurance product that moms use on a daily basis to create better health and production for themselves. The story that we told was a lot around how it benefits the doctor. But that doesn't resonate with investors. What did resonate is we have a three-part tech stack, three agentic companions holding hands across mom, the provider, and the administrative teams to curate what is a frankly a reimbursable model that helps docs make
17:07money. So that we built that substack that makes the delivery system work, reconciles perverse incentives. Until which time we had actually started talking about a three-part tech stack, the agents, and how it produces a net new data complement that can then be monetized with a first in world marketplace attached. Nobody really thought we
17:33Unidentified speaker (UNKNOWN): were More fun. Right.
17:34Unidentified speaker (speaker_0): Right. Well, they, I don't know if they still understand. I think I'm still understanding. But we had to tell the story in a way that was actually matching what was happening in Silicon Valley. Agentic was all the talk. You felt like you had to say AI to even walk in a room. Um, but then you had to actually translate the story in a way that felt real and fun and technical and investable.
18:00Nassim: The advice I've given a lot of founders is you have to essentially put the empathy in the appendix. Right. We love you, nobody cares, but you have to tell a money story and
18:08Unidentified speaker (UNKNOWN): you have to
18:08Nassim: lead with value. The tension becomes how do you balance telling a money story and feeling like you're having to leave mission behind? When you aren't, you can still do both, but you're just reordering the sentences. How did you balance those two?
18:22Unidentified speaker (speaker_0): Yeah, so you you bury it in the finance. I mean, the the way that looks is and we literally changed our narrative. And I think this is what you were trying
18:29Unidentified speaker (UNKNOWN): to
18:29Unidentified speaker (speaker_0): get at. We changed our narrative from talking about outcomes and moved it into okay, we've hit about 1.2 million ARR. We're operating at 72% gross profit margin. We reduced total cost of care by 1.2 million across 888 patients. Snap, snap, snap. And by the way, when we reduced total cost of care, we detected a emerging preoclampsia in 8% of patients. We detected suicidal ideation and rested it same day in 9% of patients. We stopped substance use disorder in four. So we just shifted the outcome to the end of the sentence and we wrapped it into total cost of care reduction for the payer.
19:08Nassim: Absolutely. And then you shift the whole conversation because you can't argue the numbers up front.
19:12Unidentified speaker (UNKNOWN): Right.
19:13Nassim: And by way, you're getting the human benefit. benefits at the same time.
19:16Unidentified speaker (speaker_0): By the way, that 1.2 million just hit 5 million.
19:21Nassim: Yeah. The other thing, and a lot of healthcare companies are figuring out how to do this, but there's typically four things an investor wants a healthcare company to do. You want it to improve the patient experience, you want it to integrate into clinical workflows. You want it to hopefully reduce costs and bonus tier. territory increase revenue for the provider, right? So everybody makes money. And not every company thinks about doing those four checkboxes. But what you've built does all four checkboxes. And that was the magic sauce when I got excited: was this isn't just about Lovu making money, but almost every provider is making something like 15 to 20% more revenue per month. when they have Lobo installed.
20:05Unidentified speaker (speaker_0): That's exactly right. And just to talk about the how of that, I'm not a woman who had a bad healthcare outcome having a child. In fact, I'm a woman who struggled with infertility and I'm unable to have children. I birthed a company. So anyone who is struggling with infertility, just know there's alternative paths. Um and I trust me, it's a child and it shits the bed. So um
20:29Nassim: I have to change its diapers.
20:31Unidentified speaker (speaker_0): What we recognized with was that the delivery system was fundamentally broken when it came to OB care. And that the only way that the delivery system was going to be able to absorb a net new solution is that that solution must bear revenue. And so before we even took anything to market, we had a rock solid. commercialization strategy. And that was really around and incubated for years within an existing delivery system in order to identify what that was. But literally sat down and said, I did a back of the napkin across the weekend because we had some great ideas on physiological surveillance and monitoring. And I was like, well, what if we connected it to ancillary services and we could actually educate mom, have a platform and help become a health producer. I've got to put something together that is going to yield between 40 to 60% gross profit margin out of the gates, is going to be revenue bearing for not only us, profoundly revenue bearing, beyond break-even quickly, but is also going to create real economic sustainability for the delivery system. Fundamentally, take a service line Echo B that's been operating in the red in years and turn turned it into a service line that is breaking. even if not operating in the black. And so that's what we've done. Our model, because we're generating so much revenue through clinical practice, they pay for our tech and services,
21:50fair market value, then the physician retains the rest. Those clinicians have then in turn used that revenue to recruit new providers, to lease new office spaces, to buy new equipment, to throw holiday parties, right? So we've made the clinician's life more sustainable. And that was a key
22:08Unidentified speaker (UNKNOWN): piece. Yeah, it
22:09Nassim: was a big deal. How did you navigate relationship building through this process? And I ask because the there's a balance, and what we see rather is that a lot of male founders are out in market all the time. They're going, they're doing all the smoothing schmoozing all the time. So
22:23Unidentified speaker (UNKNOWN): it
22:23Nassim: makes a round relatively quote unquote easy to pull together over a weekend, which is the stories we hear. Uh female founders, it tends to be harder because we have maybe all kinds of other life commitments, or we're coming into this ecosystem, you know, 20 years behind our male product parts. And so we don't have these networks built. What was your relationship strategy? How did you build? How did you create the importance with the people that you knew were gonna going to be useful?
22:48Unidentified speaker (speaker_0): Every conversation was worth jumping in a car, jumping on a plane, doing it in person. Just show up. And I know that that is not a luxury that everyone has. So it I had a great pet sitter too. The other part of this was I quickly, and this was through advisory from folks like you.
23:07Nassim: Yep.
23:08Unidentified speaker (speaker_0): I quickly began to recognize that there are rooms that are curated, particularly for female founders, that might not be the best rooms for us. They become echo chambers. They're echo chambers around, we're not getting funded. They're just hotbeds of complaint. Get in with the boys. You want to get some guys interested in your company, talk about you've got a professional across league invested in you. That was really meaningful as well. The other piece of this was I quickly began to recognize we talk about this the white hats and the dark hats, not everybody was meant for me. And if I didn't feel the conversation really attaching, if I didn't see that this individual recognized me as a human being, my authenticity, the mission of the organization, just walk away. You know instinctively when it's a match, walk away from that which doesn't have that right. It's almost spiritual chemistry. And then when you do, I identified my lead for Series A. It's That's
24:01Nassim: fantastic.
24:02Unidentified speaker (UNKNOWN): I got
24:02Unidentified speaker (speaker_0): on the road to health. I didn't have a ticket. I knew he was going to be there. I couldn't even afford to go to the room at the time. I said, I'm going to be there. I had no other appointment set up in the hopes I would just run into him in a hallway. Caught him for five minutes. It's that level of commitment to curating the moment. Build your rooms.
24:23Unidentified speaker (UNKNOWN): This
24:24Nassim: episode is being brought to you by two fantastic partners. The first is Fidelity Private Shares. Private companies get complicated fast. New investors, new option grants, new questions you can't answer from memory. Fidelity Private Shares puts cap tables, evaluations, governance, and all the planning you need all in one system. So you always know where ownership stands. It's clarity and structure before you need it. Go to FidelityPrivateShares.com FidelityPrivateShares dot com or find them on LinkedIn. The second great partner is Venturous Counsel. Council. If you're a founder or investor getting started, navigating a deal, or just trying to get the legal side right without it becoming a big distraption, Venturous Council was built for you. They're not your typical startup lawyers. Venturous Council is a mission-driven law firm that unapologetically believes that diversity is a strength, access matters, and great legal counsel can help it level the playing field. They are big law caliber, half the cost. double the speed with none of the attitude. Right now, Capital Flex listeners can get a free 30-minute consultation with a senior ventures counsel attorney. Real advice covered by attorney client privilege with zero pressure. Use promo code CAPFlex and book your free meeting at venturescounsel.com. That's V V-E-N-T-U-R-O-U-S-C-O-U-N-S-E-L E N T-U-R-O-U-S-C-O-U-N-S-E-L. dot com. If we go back to the venture debt that you've raised, I very clearly remember a 7 a.m.
25:43phone call on a Saturday when you read me and you said, holy shit, Nassim, something's wrong. Take us through what had been going on before you called me that day.
25:51Unidentified speaker (speaker_0): Oh my God. I I mean, I'm trying to I'm like actually trying to get back to the story and rem remember it well because there's almost trauma behind it. You know, effectively, what had happened. in the venture deck community is that there was so little experience with the sort of maternal health ecosystem or the femtech ecosystem. And there was such a preference for that which they already knew, that which they were already invested in. So few companies had made it to Series A. So few companies had actually been thought. thoughtful about bringing in venture debt that by the time you sat down to talk to a bank, they'd say, the economics look gorgeous. We just have no real way to vet this because we've never made a bet in maternal health or let alone women's health, or even a female founded company. They had no experience with founders like me. So they were uncomfortable. investing in me.
26:53Nassim: It was wild because once she called me with that, and I was like, well, let's just see if we can find out a little bit more. So I ran a survey on LinkedIn, got a bunch of data in from other founders. If they had raised venture debt, had they been approved, if they hadn't been approved, what had been the reason? And it was very inconsistent. It was someone had revenue, someone didn't have revenue. Somebody had contract value, somebody didn't. Somebody was in climate, somebody wasn't. There was no consistency. And then I talked to two very dear friends in banking who had been part of the venture debt teams, both said it almost has nothing to do with revenue.
27:28Unidentified speaker (UNKNOWN): The
27:29Nassim: venture debt decisions are getting based, getting done based on your cap table. And so if the credit team doesn't know your cap table, you're never going to get approved for venture debt. And I knew. nearly fell out of my chair. And I think I called you when I finally had some data in hand. And the wild thing about that is if the credit teams don't know your cap table, and if most of the female founders are getting funded by funds that are relatively new-ish in the last 10, 15 years, then all of the founders that we're funding are never going to qualify for venture debt because those credit teams don't. So the entire half of the ecosystem can't get venture debt. It's a systemic problem, right? It blew my mind because I said, this is we're talking, we talk about bias that happens out loud. This is bias that's built into decision making. So I wrote a whole LinkedIn post about it. And then we talked at length about it. And it was what we need to do, right? Is one, people like me need to become friends with the credit teams at these banks, right? So that they know who I am, they trust me and my credibility, they'll trust my fund and the checks I write. And then no
28:29founder should be going out for venture debt unless you know your cap table is known by the credit team.
28:33Unidentified speaker (speaker_0): That's exactly right. As a result of this, there was a foundational shift in the behavior of my cap table. So our lead investor built a relationship with our venture debt partner, which is their thickest thieves now. And that was a direct result of the relationship that I brought to the table. But it was, it was such a solid lesson because I mean, I was going around to all the early stage investors going, what venture debt firms do you have a relationship with? And nobody did.
28:59Unidentified speaker (UNKNOWN): Nobody did.
29:00Unidentified speaker (speaker_0): And women just hadn't gotten that far.
29:02Unidentified speaker (UNKNOWN): Yeah.
29:03Unidentified speaker (speaker_0): And if they were bold enough to have gotten that far or had a company investable enough to make it to Series A where you could actually bring on venture debt, the venture debt firms had just the banks just didn't didn't know anybody in maternity. maternal health or or femtech or the feminine world.
29:18Nassim: So it is for me it's on the it's on the funds and on the investors to create those relationships because we have to be able to smooth the path for companies like yours who are inevitably going to be looking for venture debt at some point in time. So you also early on maybe not early on uh got feedback on your deck uh that it sucked. Yes. And literally that was the word. And that uh the story was broken. Yes. How what did you do? Had you gotten that feedback before? Was that the first time? And then what did you do next?
29:47Unidentified speaker (speaker_0): I had gotten the story is not resonating, the story's complicated. And it is. The healthcare delivery system is complicated. And I started to change that language. Like you might think the delivery system is complicated, but our story is nuanced, you know? But those words, the deck sucked. And I just I I'd heard so much of the opposite as well. I love your deck. Like, which one is it? So you've really got to, you know, again, read the signal for the noise. But I knew this. I knew we had a highly investable business model and company, but that the checks weren't coming in. There seemed to be confusion and analysis paralysis. So, how do we get folks beyond that? On Did a handful of things. Um, first of all, highly coachable, right? Like, I feel like it's a season of test. Ted Lasso before Ted Lasso was out, like literally taking on the feedback of anybody who would give me feedback about how to make that deck better. And then just distilling that information into, for lack of better words, insights that we could act upon. Then we contracted out with an outside firm to really help fix the story. They they took it through a few iterations. We were still broken. At that point, because it still still wasn't resonating. I took that work and I had a dear, dear friend who had worked with me at one of the top sales engines in the world, which, well, it still is called the advisory board company for folks
31:07who know that who that is in healthcare. She was effectively their back end engine, always touching on the story. And a dear friend of mine, I'd worked with her when I was at the advisory board. I called her and I said, Deck's broken, can you fix? And she's like, Sister, this thing is not, it's not elegant. It's got too much data on it. It's confusing. We rebranded, we reframed, we retold the story. And then the deck looked expensive. The deck read like something that would come straight off a scene. sandhill road. And the deck did something right up front. It led with our stats on revenue. Here's our revenue. Here's how many moms on platform. Here's our gross profit margin. Here's our TAM. By the way, if you think about our TAM as extrapolated to not only all women, but all individuals who live in the United States, it's a one trillion dollar annual opportunity. All of a sudden it got sexy. right? So that leading with those stats right out of the gates, leading with an expensive looking brand. And then, oh, by the way, I'm going to show you how the tech works. When they saw those first couple of slides, nobody cared how the tech worked. You just got to lead with the punch right out the gates.
32:17Unidentified speaker (UNKNOWN): Yeah.
32:17Nassim: The uh balancing preciousness around the story with actually taking constructive feedback and finding a way to implement it is something that I I coach a lot of founders on because it can be hard. Because you know, this is I've always told the story this way. Why would I tell it a different way? Why would somebody else touch the story? But it can make such a difference to how you end up showing up
32:37Unidentified speaker (UNKNOWN): in a row.
32:37Unidentified speaker (speaker_0): Absolutely. And you need a deck you can get through in five minutes and a story you can get through from the beginning to the end. Yeah, five
32:44Unidentified speaker (UNKNOWN): minutes.
32:44Nassim: 100%. One last question, then we'll open up for QA. Uh it was something you've said a few times is that if we weren't going to build it unless it could commercialize.
32:53Unidentified speaker (UNKNOWN): Oh,
32:53Unidentified speaker (speaker_2): for sure.
32:54Nassim: And that can be a really hard line in the sand on when
32:57Unidentified speaker (UNKNOWN): you
32:57Nassim: decide what to do or what not to do. How has that driven your decision making since the beginning? And has it ever gone wrong?
33:04Unidentified speaker (speaker_0): So we have two pillars for whether or not we move on a strategic decision for a hire, or whether or not we're gonna add a bell on the Christmas tree for. product. That is, is it going to bear revenue and is it going to provide a better outcome for our mother? Those are our guideposts. We don't make a move without those being in place. I think the strongest value proposition our firm has ever had, besides the fact that we have a such a powerful positive impact on on the lives of women and children, is the fact that it's a highly commercializable. and continues to be multifactorial revenue bearing model.
33:43Nassim: Yeah.
33:43Unidentified speaker (speaker_0): Right. Um I there's so much slick, gorgeous tech without a great revenue story behind it. And those folks still come to me and I'm like, good luck selling it. And no, I'm not going to give you all our CPT codes. Right. Like figure out your revenue story, then you build your tech to support it.
34:01Nassim: Yeah. Absolutely. Do we have any questions from we can probably do two or three? Hi Annie. It's nice to see you. Hi
34:07Unidentified speaker (speaker_0): Annie.
34:09Nassim: So your question was uh how do you navigate investors who understand infrastructure and technology versus those who don't? Uh and does it change whether you actually spend time educating, or do you just continue to focus on those who get it in the first place?
34:25Unidentified speaker (speaker_0): Those of us who are designing novels. novel models, be it AI models, be it a new healthcare delivery model that is difficult to wrap your your head around. One of two things is going to happen. Either someone is going to and Jessica Kamata
34:38Unidentified speaker (UNKNOWN): said
34:38Unidentified speaker (speaker_0): this. She said, I didn't understand what the hell was going on, but I liked you, I saw you speak, and I just saw revenue. So that's
34:45Unidentified speaker (UNKNOWN): the
34:45Nassim: exact opposite of that other investor.
34:46Unidentified speaker (UNKNOWN): The other investor, right? But
34:47Unidentified speaker (speaker_0): she's like, So I I I need to come in, I'll figure it out later. If they didn't have the intelligence or the emotional quotient to figure it out, I moved on. And the most important thing to know is sometimes they're just not going to take the time to understand, to get deep into the vertical, to really figure it out. And what I ended up doing is just saying, I've got a 10X or 100x my conversations. I spoke to thousands of people. before we actually curated enough to get our pre-seed extension together. Thousands. Every no is closer to your yes. Take the feedback from the conversation that might not have gone as well as you want. Don't spend the time trying to educate somebody onto as a vertical they should be educating themselves onto. Pass on to the person that either inherently gets your mind. model and says, no brainer. We had a group of Sandhill Angels came in on our round. Um, they got it. They're docs, a lot of docs involved in that. And they're like, oh, no brainer coming in. The other side of that is you will find individuals. I had some really large angels that came in and said, I just
35:55believe in you. So that combination of those two coming together, I spent very little time trying to educate. investors on to the machinations of a healthcare delivery system that's inherently broken.
36:07Nassim: I read something recently on Instagram that can be so fun at 2 a.m., right? I read something that said, if you knew for sure that you would go through a hundred no's before you got to that one yes, how fast would you want to get through those no's? Yeah. Right. And that I was like, oh my God, we should think about that all the time,
36:24Unidentified speaker (speaker_0): right? I love the nos. It's through the nose no's that the deck. got so damn good. Yeah. Right. Like every no becomes information that you can you're like, oh, I know this objection's gonna come up. I'm gonna preempt it. It just absolutely makes your pitch as close to perfect as possible, the more no's you get.
36:40Nassim: Another question? Her question was talk to us about how you're thinking about and designing revenue projections in a market where reimbursement is highly unpredictable.
36:50Unidentified speaker (speaker_0): I'm fortunate. that a vast majority of our model lies within CMS-based codes that are tried and true and are actually showing year over year improvement. However, a few of the codes that we work with are at risk. And I think the most important thing is to be designing technology for a future state, knowing that you will be disrupted. The delivery system that exists today will not be here in five years, let alone 10. We have, as a team, as a product team, at a leadership team, even our board, we have a foot in two boats. One is our current state and maximizing revenue associated with what is happening today. And we have spent time really building channel partnerships with firms that are much larger than us, that have billion dollar valuations that are doing some of the heavy work around policy making at the federal level. So we've built those partnerships that care about the same CPT codes that we care about or the same levels of reimbursement that we care about. All the while, I am very clear with my investment community we are designing this company and the product within it for a future state where we do not need to be dependent on a CPT. coding-based model. Lovely if we can get that additional reimbursement, but there is a world where for $99
38:09a month, every mom has our product. Now it might be subsidized by her employer, it might be subsidized by her payer, she might come out of product, her own product, it might come from insurance reimbursement. But the ability to say, I'm gonna get enough moms on platform, grow this large enough. so that we don't have to be so dependent. Resource dependency is what destroys great product, is what introduces unnecessary risk. It's what's frankly crushing our healthcare delivery system.
38:40Nassim: Oh, absolutely. It's it's a great way to think about it because we also on the investor side, right, we talk a lot about business models that anchor on reimbursement and and/or
38:49Unidentified speaker (UNKNOWN): or
38:49Nassim: anchor on cash pay. or have some combination. Right. And there's a school of thought that will say if they aren't hooked to reimbursement, there's no way. There's no scale. And I fundamentally disagree because there are so many other ways something can get paid for. And I have one of my other favorite checks I wrote is into a company that is a full cash pay business and went from a 30 million valuation to 250 million. It's a cash pay free business and they're doing extremely well. So there are different ways to come at the healthcare model, but being really creative, to your point, and strategic about line of sight on where it's headed is really what it
39:23Unidentified speaker (speaker_0): comes down
39:23Unidentified speaker (UNKNOWN): to.
39:24Nassim: Ultimately.
39:25Unidentified speaker (speaker_0): And socializing that with your leadership, your board, your investors right out of the gates. Well, here's where we are today. And the revenue model is much stronger per mom. But in a future state, these codes might not exist. We need to prepare for that. By the way, it might be the right. answer because the model could be 90% agentic. And why do you even need human beings attached to it? Right, exactly. Right? So that's going to be far more cost effective model. And this is going to cost X and it'll be reimbursed by an FSA as opposed to an insurance company.
39:51Nassim: Yep. Absolutely. One more. Caitlin? So her question was I've heard venture debt stories go really badly. And then so how did you think about that? Did you consider that before going after venture debt? And how did your how did your cap table respond to you seeking venture debt? The cap table was thrilled because they saw a line of sight into break-even without having to put more cash in. That was really, really exciting for them. Venture debt is tricky because you're there are revenue covenants attached. You have to be
40:20Unidentified speaker (speaker_0): absolutely so confident in your business model. So our revenue covenants are we had to hit five 5 million ARR. and I had to grind the team to get to 5 million ARR well in advance of we just hit it, or we're on the precipice of hitting it. We had to be there by December of this year. So we'll be probably at 6'1 to 6'9 by the end of the year, in excess of what the venture debt covenants require. Strong operations is what's required, very lean and mean operations to get to what a venture debt relationship will afford you. So you've got to be an integrity. You also have to be highly transparent. So your PLs, your books need to be open at any second. You need to be 1,000% auditable. Not every company is prepared for that. So you can't be a smoke and mirrors company. You have to be a hard, cold, revenue revenue-bearing, bearing, well well-run run company, a company that, frankly, could, I could dial back the company today. You know, I would never lay
41:18Unidentified speaker (UNKNOWN): off a
41:18Unidentified speaker (speaker_0): third of the team. We'd break even. We could be a small business just running. You've got to operate like a small, successful small business in order to partner with a venture debt organization. I think the other side of it is the principle matters. The person. And Paul, you know Alex over at Live Oak. Alex is a guy who's got some babies, who's seen some tough pregnancies, who really resonated with what we were doing. He was mission connected. He was running through an airport at SFO, taking a call with me, and completely got our model and wanted to come in because he believed in the product, what we could do for women. So he was mission-oriented. We just did a small All internal round. He wanted to meet our investors where they were. And actually, we designed something really beautiful. about extending out the period of time that we can be interest only on payments so we can help to make break even faster. I think that's another piece of venture debt. Most folks are just starting to learn what it means to actually get dilutive capital. Put yourself through a crash course on what it means to take on venture debt and get really good, let Claude, let ChatGPT be your guide and be your friends, because they can teach you a lot. Learned a lot about what were additional terms that we could negotiate into our venture debt relationship so we could make it more flexible for us so we could get to break even faster. Yeah. But it's it's tricky
42:38because when those payments start, they crush.
42:40Nassim: You have to be ready to take on those venture debt payments. We have two. Okay, Alex, you go. We'll do one more. So she asks you mentioned leading the deck with the financials and the metrics. How involved were you as a founder in putting those financials together and building that financial model such that it could lead the story?
42:58Unidentified speaker (speaker_0): I am the financial model. Um my finance team, my revenue team, and I speak daily. A founder who doesn't know how much cash she has on hand, what a gross profit margin is, what her financial productions are, will drown, then die. You must live and breathe your PL.
43:17Nassim: Yeah. And it's not a core skill set for a lot of people. Was it a core skill set for you, or did you have to learn it?
43:24Unidentified speaker (speaker_0): You know, I I suffered and survived HCA. So I mean, I wouldn't say it was a core skill set. It's certainly not where my mind likes to go, but I was incredibly enamored with the economics of what we were producing. Yeah.
43:39Unidentified speaker (UNKNOWN): I
43:39Unidentified speaker (speaker_0): was addicted to looking at it daily. And it was less about who was paying an invoice and just what was the revenue associated with what the model was bearing. And for me, I was terminally curious about it because I knew we'd just built a new healthcare delivery model. And as much as it produced healthcare outcomes, it was producing new revenue that had not been generated previously. So I just from pure academic exercise, I was curious. Yeah.
44:04Nassim: And there's a lot of founders who will bring on support to help them build their financial models, or they just never have run a PL before. Did you bring on support to build yours? Was it
44:15Unidentified speaker (UNKNOWN): wanting
44:15Nassim: to put that together?
44:16Unidentified speaker (UNKNOWN): Yeah. It's a
44:17Nassim: pain point I hear a lot.
44:18Unidentified speaker (speaker_0): So, I mean, when we think about our first three year operating budget, I had a chief operating officer that took a first pass and then I went in and slashed it, really corrected the assumption. assumptions, how many patients per navigator, what the tech is going to cost, what how to think about allocation, gross profit margin. So I spent a lot of time there. What I didn't know, I did teach myself. And then I've never let it go. We have brought in various firms because it's a very sophisticated model. I will say, not having a strong accounting firm.
44:51Nassim: can make a huge difference. Can
44:52Unidentified speaker (speaker_0): make a I mean you really need a tight accounting firm. And Paul helped us here uh because he saw some weaknesses and our our our numbers and our model and we directly switched who supported us from a PL perspective as a result of having
45:06Unidentified speaker (UNKNOWN): gone
45:07Unidentified speaker (speaker_0): through the Marble Bridge process.
45:08Nassim: That's great. Good advice makes a huge difference. One more she asked how did you get your first checks in well before you had the flashy numbers to support it?
45:18Unidentified speaker (speaker_0): I was working for a different company, and I was supposed to be positioning a deal on behalf of another company. And this is where it gets spiritual. And I wish I could say that it doesn't have hoodoo voodoo or a little bit of woo attached. I sat down at a table in in San Antonio, Texas, across from an individual who was supposed to help position me in a healthcare organization. on behalf of a completely different company. And he looked at me and he said, There's a story behind you I don't know. And I said, I'm working on something. And I started articulating the vision. And he had just lost his nephew, who was getting ready to be born in a very complicated third trimester, should have never happened situation. Tears running down his face. He said, I believe in you, I believe in what you're building. I'm actually curating an SBV right now. They named that SBV Magella after the uh patron saint
46:10Unidentified speaker (UNKNOWN): seen
46:10Nassim: Magella on your
46:11Unidentified speaker (UNKNOWN): cap table and
46:12Nassim: didn't know the story
46:13Unidentified speaker (speaker_0): out of the patron saint for for pregnancy. And then they cut 1.2 million in. Now that was the hardest 1.2 million I've ever operated against. I had to put together strong milestones. I had to put together an operating plan. and march towards that. And then I got checks from our customers. Our customers believed in the model so much they invested 50,000, 100,000. And there were a handful of beautiful people in my family, a handful of really strong personalities that I met that believed in the founding journey. And again, thousands and thousands of conversations. you will lose your voice.
46:52Nassim: Yeah, you know what I love about that is there's two things in there. One is maybe there's three, clarity of vision and knowing what you wanted the thing to be, which I think we can all work on. And I coach founders on this a lot, is it has to be powerful and substantial, and emotion still matters, right? There's often, like I said earlier, put the append empathy in the appendix. but you do have to layer some human intention into what you're doing, and you were able to do that. The second is that there's no moment you're not fundraising. And wherever you are in any conversation, that person could be a check. And so you just never know what's going to convert. And then the third is one of the providers who I know is on your cap table, who I met during diligence, when I asked him, you know, you've had Lobo Logo in the office for for eight or nine months. now. How's it going? And what he said was, and this this for me sealed diligence all the way through. He said, you know, it's really gonna sound strange, but the office has gotten really quiet. We just aren't having the emergencies we used to have. And it was that that kind of mic drop response to the product that was so tangible so quickly that I think also led the way. on what you were doing. And I it's so clear in my mind that conversation because I was like, oh, we're done. We're writing the check. That's it.
48:08Unidentified speaker (speaker_0): You know, I will say the biggest lesson learned, and if there is a gift in the woman who told me I needed to code shift, there's always a gift, even in the worst feedback. Angels respond differently than venture. Yeah. Completely different storylines, completely different narratives. Angels want to know. They're angels that they're making. a difference. And sometimes it's the easiest checks to raise because they attach to people, they attach to vision. My favorite angel check, I had just come from launching a small practice in Santa Barbara. I'd had celebratory margaritas, my Uber comes to pick me up. I'm three in. I'm slurring my words.
48:49Unidentified speaker (UNKNOWN): And
48:49Unidentified speaker (speaker_0): he's like, What are you doing? And he's got a gorgeous car. I'm thinking, why is this guy driving an Uber? And I start telling him about Lovu. And he says, Well, are you taking investment? And I was like, you know, cocky answer because I've received said feedback. Well, you've got to be liquid for blah, blah, blah, blah, blah. And he's like, Lady, I've had three exits. Do you think I'm an Uber driver? Ever, Like for my real regular job? I'm bored. Um, Alan Nunn now runs logistics for all. of Lovu and was one of our largest angel investors. And he shows up to our uh semi buy every other month investment meeting. You're selling in your Uber, you're selling everywhere. That's
49:26Nassim: brilliant. I love it. Last question for sure. What are your top three must-nos for female founders?
49:33Unidentified speaker (speaker_0): Save the men in this room. Man will patch pat you on your ass, a woman'll woman will save it. Number one. Really, as much as that community can be a little bit of a hen house, and I use that term with love, rest on the girls. I think show your numbers, earn your numbers, really put up the revenue. You're gonna have to bootstrap and operate off really leanly off of a handful of angel checks until you, which time you get that revenue up there. And then the last but not least is the resilience. the level of investment back into yourself, the making sure you're controlling everything you can. And what I mean by that is have rituals set up, your daily green drink, being in bed by a certain time, be it a yoga practice, physical practice of relieving stress and doing these things daily. The most important part of this process is not, can you tell a story? Is not can you raise Is not, is your product working? Is as you are the founder. Are you resilient enough to move through this? It will rock you. It will crack you.
50:37Unidentified speaker (UNKNOWN): You
50:37Unidentified speaker (speaker_0): just got to be able to tether yourself back together.
50:39Nassim: Thank you so much for joining us, for sharing the knowledge, for bringing just an incredible base of insight to this room and to the podcast. And I'm such a fan. so thank you so much.
50:53Unidentified speaker (speaker_0): Thanks everyone.